tbd

Martin Hodosi is a Partner at Kearney and drives the North America pharma R&D advisory services, bringing over a decade of consulting experience. He has collaborated with some of the world's largest companies to tackle their most significant challenges in clinical development, operating model, and post-market obligations. His work includes accelerating time-to-market for innovative treatments and improving the cost of bringing new treatments to market.

Christine joined Sanofi in August 2002 as a HR Business Partner for the Commercial Operations organization.  She was promoted several times with increased responsibilities in the Commercial and Support function organizations where she led multiple initiatives around re-organizations and strategic staffing.  In 2010, she became the Business HR partner to the Head of Commercial Operations, where she focused on all aspects of building organizational capabilities around leadership development, staffing, talent management, and performance rewards and recognition. 

In June 2014, she moved into the role within Sanofi as Head of Talent Management for North America where she led a team focused on talent management, performance management and career development across the North American portfolio of businesses. Christine was also responsible for several talent accelerator programs to develop the next generation of leaders as well as managed the Executive and Internal Coaching programs.   In 2016, Christine took on a Global role regarding Talent Management programs where she developed early career to mid-level programs to continue to build the leadership pipeline including the development and global deployment of an early career development center and a high-potential female talent program.   In November 2018, Christine was promoted to the  Global Head, People Development Learning Institute, where she led the People Development Learning Institute. She was responsible for the design and implementation of learning and development strategy and related solutions for all levels of leadership, management and transversal skills on a worldwide basis for Sanofi.

Most recently in April 2021, she assumed her current role as Global Head, Talent Management where she leads the Talent Management and Early Career strategy and approach for Sanofi. She supports the succession planning efforts to ensure a strong leadership pipeline for today and tomorrow.

Christine holds her Masters degree in Human Resources from University of Scranton.  She is a credentialed coach (PCC), Hogan Certified,  PROSCI certified for Change Management, Insights Discovery and DISC certified and is a Senior HR credentialed professional (SPHR).  

Jonathan has over 20 years of multidisciplinary experience in regulated medical products (drugs, biologics, medical devices, and combination products) at multiple global companies, with practical experience in drug delivery-focused Development/Engineering, Quality Assurance, and Regulatory Affairs for various combination product types. His specialties include digital health (including smart packaging/connected devices and software as a medical device, or SaMD) and in vitro diagnostics, along with clinical development (bridging) and lifecycle management for combination products. Jonathan earned his BS in Chemical Engineering from Northwestern University and is ASQ certified as a Manager of Quality/Organizational Excellence and a Quality Engineer. In his "free time,", Jonathan engages with the global combination product community by speaking at conferences, lecturing in courses, serving key roles within prominent industry organizations, and interfacing with regulators on a variety of topics.

Yi Hong, PhD is a clinical data scientist with a strong foundation in AI-driven operational analytics, trial design and real-world data. Currently Associate Director at Gilead Sciences, he co-leads strategic initiatives to evaluate the impact of the Gilead Trial AI. His work includes developing operational metrics, leveraging real-world data for protocol design, and AI agentic solution to forecast and optimize trial enrollment. Previously, Yi was a Data Scientist at Verana Health, where he built scalable data quality infrastructure for EHR platform. His earlier leadership at Topchoice Medical in China included founding a Center of Operational Excellence, where he led cross-functional teams to implement AI/ML solutions for patient journey mapping, treatment optimization, and predictive modeling. Yi holds a PhD in Engineering from the University of Cambridge and has published in applied physics and nanoelectronics. His interdisciplinary expertise bridges clinical research, health tech innovation, and advanced analytics, making him a key contributor to the future of AI-enabled clinical trials.

Thérèse Menear is a seasoned and experienced leader within the drug development space, specifically within clinical trial operations and execution. She joined Exelixis in September 2022 and during her tenure has served as Vice President, Clinical Operations and most recently, she has assumed the role of Vice President, Operational Excellence. From November 2006 to September 2022, Thérèse was at GSK where she held many roles of increasing responsibility, to include Vice President, Global Pharma Clinical Delivery in which she led a global team of approximately 300 members across approximately 200 clinical trials. Prior to GSK, Thérèse was a member of the Project Management (PM) team at Covance, a contract research organization, where she eventually led the North American PM Team, a team of 75 seasoned PM professionals. She started her career at Clinical Research Group, an oncology site management organization and over her 5 years with CRG, she helped grow the company from a 4 to 50 person company while serving as a member of the executive leadership team; Thérèse credits this initial experience to the start of her 30+ year career helping to bring new medicines to patients in need. Thérèse holds a BA degree from University of Scranton in International Languages & Business. She resides in Havertown, PA, with her family.

Michele Sample is a trained clinical operations expert with over 30 years of clinical trial experience.

Michele joined AstraZeneca in 2020 as the Vice President of Late Development Oncology Clinical Operations and leads a global team of clinical operations experts to execute the Oncology portfolio. Michele is directly responsible for global clinical trial delivery including program management, study management, site management and monitoring, managing approximately 1,600 people.  

Before joining AstraZeneca, Michele was responsible for global development operations at Incyte, including clinical operations, medical writing, data management, monitoring and clinical trial logistics. Prior to this, Michele held varying leadership positions at GSK, Novartis, Covance and a small biotech company which contributed to the approval of multiple cancer medications.

Michele is passionate about reimagining clinical trial execution with a focus on site engagement and decentralization of clinical trials. Her main research interests include oncology clinical trial execution excellence, increasing diversity in clinical trials and reducing health disparities.  

Michele holds a Bachelor of Science in Nursing from Widener University and a Master of Clinical Research and Organizational Management from Drexel University. 

Experienced, driven, and innovative Life Sciences and Technology Professional with a strong track record of delivering impactful solutions and driving operational excellence across the drug development continuum. With expertise spanning the full drug development lifecycle, I specialize in aligning business strategies with forward-thinking IT solutions to enhance and accelerate clinical development outcomes.  Collaborating with TransCelerate to lead industry-wide digital transformation through the Digital Data Flow initiative that enable seamless interoperability from study design to regulatory submission.

I hold an MBA from Boston University’s Questrom School of Business, with a concentration in Innovation, Management, and Strategy, and a Bachelor’s degree in Computer Science. I am also actively engaged in nonprofit STEM initiatives for children and contribute to advancing education for women and children.

tbd

tbd

Melanie Goodwin is the Director of Clinical Outsourcing, bringing over a decade of experience in clinical operations and strategic vendor management. At the forefront of optimizing clinical trial delivery, Melanie leads cross-functional collaborations that drive efficiency, quality, and innovation in global development programs. Her expertise spans outsourcing strategy, governance, and relationship management, making her a trusted leader in navigating the complexities of clinical partnerships. Based in Conshohocken, PA, Melanie is passionate about advancing clinical research through thoughtful collaboration and operational excellence.